FN2 Earnings Intelligence
DuPont de Nemours, Inc. earnings overview
Latest DuPont de Nemours, Inc. (DD) earnings intelligence, including the newest scorecard, market reaction, and transcript analysis.
DuPont de Nemours, Inc.
The supplied analysis supports a constructive near-term operating picture: resilient demand in healthcare, water, aerospace, and EV battery applications combined with productivity initiatives helped DuPont raise its full-year outlook. The thesis remains dependent on execution, price-cost neutrality, and the timing of Middle East projects.
DuPont de Nemours, Inc.
DuPont's Q1 FY2026 results materially exceeded expectations, with EPS of $1.65 against a $0.49 consensus estimate and 2% organic sales growth paired with 130 bps of margin expansion. The beat was powered by healthcare packaging, water technology, and EV battery adhesive demand, supplemented by interest income from the completed $1.2B Aramids divestiture. Management raised full-year guidance and announced a $275M accelerated share repurchase, signaling confidence in the operating trajectory. The stock rallied 8.4% on heavy volume following the report. Key uncertainties include Middle East logistics disruptions, construction-end-market weakness, and the execution of the 80/20 portfolio optimization.
DuPont de Nemours, Inc.
The supplied analysis supports a measured version of the growth hypothesis: innovation, resilient healthcare and water demand, and productivity can support the 2026 outlook, but regional softness, industrial order trends and execution remain important tests.
DuPont de Nemours, Inc.
The supplied analysis supports a constructive operating case for DuPont: growth in AI-related electronics, healthcare and water, alongside raised guidance and margin initiatives. The case remains dependent on execution after the Qnity separation, debt reduction, and resilience in construction-exposed operations.
DuPont de Nemours, Inc.
The current analysis supports a constructive operating picture: AI-driven electronics demand, advanced packaging volumes, and Healthcare & Water growth outweighed construction weakness and supported raised full-year earnings guidance. The thesis remains dependent on execution of the Qnity spin-off, continued demand, and containment of tariff, China, pricing, and environmental risks.
DuPont de Nemours, Inc.
The current analysis supports a constructive but conditional view: electronics demand tied to advanced nodes and AI, alongside growth in water and healthcare, supported first-quarter performance and maintained guidance. The thesis remains dependent on tariff mitigation, execution of the Qnity separation and containment of legal and regulatory risks.
Get the DD recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.